Lifitegrast ophthalmic solution 5.0% for treatment of dry eye disease: results of the OPUS-1 phase 3 study. [electronic resource]
Producer: 20140327Description: 475-83 p. digitalISSN:- 1549-4713
- Administration, Topical
- Adult
- Aged
- Aged, 80 and over
- Conjunctiva -- metabolism
- Cornea -- metabolism
- Double-Blind Method
- Dry Eye Syndromes -- drug therapy
- Female
- Fluorescein -- metabolism
- Fluorometry
- Humans
- Lissamine Green Dyes -- metabolism
- Lymphocyte Function-Associated Antigen-1 -- drug effects
- Male
- Middle Aged
- Ophthalmic Solutions
- Phenylalanine -- administration & dosage
- Prospective Studies
- Staining and Labeling
- Sulfones -- administration & dosage
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.